Status:
COMPLETED
The Neutrophil-to-Lymphocyte Ratio to Exclude Pancreatic Fistula
Lead Sponsor:
Institut Paoli-Calmettes
Conditions:
Pancreas Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
There is still no consensus on whether drain fluid amylase (DFA) level, C-reactive protein (CRP) level, or complex scores predict clinically relevant postoperative pancreatic fistula (CR-POPF). The ai...
Detailed Description
From January 1, 2012 to December 31, 2020, consecutive patients underwent PD performed at Institut Paoli-Calmettes for various pathologies. Data were entered prospectively into a clinical database (NC...
Eligibility Criteria
Inclusion
- Patients who underwent pancreatoduodenectomy
Exclusion
- Total pancreatectomy
- Enucleation
Key Trial Info
Start Date :
June 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2021
Estimated Enrollment :
648 Patients enrolled
Trial Details
Trial ID
NCT04724551
Start Date
June 1 2012
End Date
February 28 2021
Last Update
May 28 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.